GGrantIndex
← Leaderboards

Solomon Fiifi Ofori-Acquah

University Of Pittsburgh At Pittsburgh

$18,588,176
Attributed
$29,356,981
Total exposure
14
Grants
10
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $4.4M · FY200525
$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25

Funding mix

By agency

NIH$34,904,784 · 15

By mechanism

U01$10,820,980 · 2
R01$9,343,606 · 4
U54$7,560,219 · 3
P20$3,880,361 · 2
K12$1,729,859 · 1
R25$1,056,204 · 2

Most similar at University Of Pittsburgh At Pittsburgh

Same institution · by research overlap

Others in their field

Top investigators on “Sickle Cell Anemia

Research focus

Sickle Cell AnemiaResearch PersonnelLungTrainingCareerPhenotypeSiteProgramsScientistUniversitiesAreaTissuesAfricaMorbidity - Disease RateSkillsFunctional DisorderCellsBlood VesselsHemolysisMolecularSickle CellAffectHemeOrgan

Grant awards (75)

Therapeutic Targets in Acute Chest Syndrome$678,698
R01 · FY2025 · HL · contact PI
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium$350,302
U01 · FY2025 · HL
Therapeutic Targets in Acute Chest Syndrome$675,749
R01 · FY2024 · HL · contact PI
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium$331,151
U01 · FY2024 · HL
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$125,280
R25 · FY2024 · HL
Therapeutic Targets in Acute Chest Syndrome$689,540
R01 · FY2023 · HL · contact PI
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium$268,617
U01 · FY2023 · HL
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$122,040
R25 · FY2023 · HL
Therapeutic Targets in Acute Chest Syndrome$685,023
R01 · FY2022 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$391,026
K12 · FY2022 · HL
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium$265,269
U01 · FY2022 · HL
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$122,040
R25 · FY2022 · HL
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa$1,088,120
U54 · FY2021 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$415,675
K12 · FY2021 · HL
Genetic determinants of hemolysis modifying defense in sickle cell disease$229,377
U54 · FY2021 · HL · contact PI
Ghana-SPARCO: Ghana Sickle Pan-African Research Consortium$227,633
U01 · FY2021 · HL
Administrative Core$152,922
U54 · FY2021 · HL · contact PI
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa$1,094,400
U54 · FY2020 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$411,577
K12 · FY2020 · HL
Genetic determinants of hemolysis modifying defense in sickle cell disease$256,187
U54 · FY2020 · HL · contact PI
Administrative Core$135,144
U54 · FY2020 · HL · contact PI
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa$1,103,323
U54 · FY2019 · HL · contact PI
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis$668,614
R01 · FY2019 · GM
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$412,499
K12 · FY2019 · HL
Genetic determinants of hemolysis modifying defense in sickle cell disease$253,007
U54 · FY2019 · HL · contact PI
Administrative Core$137,116
U54 · FY2019 · HL · contact PI
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa$1,081,887
U54 · FY2018 · HL · contact PI
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis$668,614
R01 · FY2018 · GM
Genetic determinants of hemolysis modifying defense in sickle cell disease$256,465
U54 · FY2018 · HL · contact PI
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$154,614
R25 · FY2018 · HL · contact PI
Administrative Core$139,493
U54 · FY2018 · HL · contact PI
Pittsburgh HIV Mentored Training for Investigation of Co-morbidities and Cure (HIV MeTrICC)$99,082
K12 · FY2018 · HL
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$1,909,806
U01 · FY2017 · HL
SickleGenAfrica:Sickle Cell Disease Genomics Network of Africa$1,180,073
U54 · FY2017 · HL · contact PI
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis$668,614
R01 · FY2017 · GM
Genetic determinants of hemolysis modifying defense in sickle cell disease$246,953
U54 · FY2017 · HL · contact PI
Administrative Core$205,752
U54 · FY2017 · HL · contact PI
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$151,374
R25 · FY2017 · HL · contact PI
Pittsburgh Intensive Training in Hematology Research$76,494
R25 · FY2017 · HL · contact PI
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$1,909,806
U01 · FY2016 · HL
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis$668,614
R01 · FY2016 · GM
Mechanisms of endothelial barrier phenotypes in sickle cell disease$495,110
R01 · FY2016 · HL · contact PI
Pittsburgh Undergraduate Research Diversity Program (PURDIP)$151,374
R25 · FY2016 · HL · contact PI
Pittsburgh Intensive Training in Hematology Research$76,494
R25 · FY2016 · HL · contact PI
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$1,881,158
U01 · FY2015 · HL
Role of erythroid DAMP molecules in the pathogenesis of vascular injury in sepsis$668,614
R01 · FY2015 · GM
Mechanisms of endothelial barrier phenotypes in sickle cell disease$379,225
R01 · FY2015 · HL · contact PI
Mechanisms of endothelial barrier phenotypes in sickle cell disease$110,110
R01 · FY2015 · HL · contact PI
Pittsburgh Intensive Training in Hematology Research$76,494
R25 · FY2015 · HL · contact PI
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$50,298
U01 · FY2015 · HL
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$1,729,411
U01 · FY2014 · HL
Cellular and Molecular Mechanisms of Acute Lung Injury in Sickle Cell Disease$1,897,529
U01 · FY2013 · HL
Mechanisms of endothelial barrier phenotypes in sickle cell disease$354,973
R01 · FY2013 · HL · contact PI
Mechanisms of endothelial barrier phenotypes in sickle cell disease$13,927
R01 · FY2013 · HL · contact PI
Mechanisms of endothelial barrier phenotypes in sickle cell disease$387,500
R01 · FY2012 · HL · contact PI
LOSS OF ALCAM FUNCTION: TUMORIGENESIS & DISPARITY IN BREAST CANCER$415,652
P20 · FY2011 · MD · contact PI
RESEARCH TRAINING AND MENTORING CORE$405,177
P20 · FY2011 · MD · contact PI
Mechanisms of endothelial barrier phenotypes in sickle cell disease$387,500
R01 · FY2011 · HL · contact PI
Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes$102,711
K02 · FY2011 · HL · contact PI
LOSS OF ALCAM FUNCTION: TUMORIGENESIS & DISPARITY IN BREAST CANCER$292,512
P20 · FY2010 · MD · contact PI
RESEARCH TRAINING AND MENTORING CORE$285,140
P20 · FY2010 · MD · contact PI
Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes$102,711
K02 · FY2010 · HL · contact PI
LOSS OF ALCAM FUNCTION: TUMORIGENESIS & DISPARITY IN BREAST CANCER$337,797
P20 · FY2009 · MD · contact PI
RESEARCH TRAINING AND MENTORING CORE$329,285
P20 · FY2009 · MD · contact PI
Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes$102,711
K02 · FY2009 · HL · contact PI
LOSS OF ALCAM FUNCTION: TUMORIGENESIS & DISPARITY IN BREAST CANCER$1,374,054
P20 · FY2008 · MD · contact PI
Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes$102,711
K02 · FY2008 · HL · contact PI
RESEARCH TRAINING AND MENTORING CORE$1,385
P20 · FY2008 · MD · contact PI
LOSS OF ALCAM FUNCTION: TUMORIGENESIS & DISPARITY IN BREAST CANCER$395,341
P20 · FY2007 · MD · contact PI
Role of CD166/ALCAM in Lung Endothelial Barrier Function$290,143
R01 · FY2007 · HL · contact PI
Lung Endothelial Barrier Function and its Deregulation by Sickle Erythrocytes$102,711
K02 · FY2007 · HL · contact PI
RESEARCH TRAINING AND MENTORING CORE$44,018
P20 · FY2007 · MD · contact PI
Role of CD166/ALCAM in Lung Endothelial Barrier Function$285,138
R01 · FY2006 · HL · contact PI
Role of CD166/ALCAM in Lung Endothelial Barrier Function$292,000
R01 · FY2005 · HL
Role of CD166/ALCAM in Lung Endothelial Barrier Function$275,900
R01 · FY2004 · HL